NYXH Nyxoah, S.A.: Earnings per share for the last 12 months

Nyxoah S.A (NYXH) - corporate logo

This market valuation chart for Nyxoah S.A. (NYXH) demonstrates the 19.60 metric, while the business relies on a steady demand for treatment despite logistics and sanctions risks. The development of an innovative implant for sleep apnea ensures patient comfort, enabling the company to maintain pricing power. The growth strategy is based on independently achieving medical milestones without mergers, focusing resources on the US market.

NYXH Nyxoah S.A: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/18/2026

Financial and market metric breakdowns for Nyxoah S.A (NYXH)

- market price and analyst price targets:
Initial company analysis:Nyxoah S.A.
Product sample of Nyxoah, S.A.

Nyxoah S.A. is scaling the implementation of the Genio system for apnea therapy as it seeks expansion into the US market. This operational activity directly impacts net income dynamics, which this indicator measures via the rolling annual EPS growth. The metric captures the rate of earnings per share generation, allowing for an assessment of business efficiency from a fundamental perspective. By analyzing the YoY ttm net income per share changes on GURU.Markets, an investor can identify the risk of asset overvaluation when multiples are inflated.

Competitor analysis for Nyxoah S.A.

Net earnings per share for the last four quarters Intuitive Surgical, Inc. ISRG|Danaher Corporation Inc. (DHR) - Earnings per share for the last twelve months|BDX - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months STE|WST (westpharma.com) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Baxter (BAX)|Earnings per share for the last four quarters MASI|Earnings per share for the last twelve months Stevanato STVN|Net earnings per share (EPS TTM) Teleflex Corp TFX|MMSI: Net earnings per share for the last 12 months|NVST - Net earnings per share (EPS TTM)|ICU Medical Inc (ICUI) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Dentsply Sirona|LMAT (lemaitre.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AtriCure Medical ATRC|Earnings per share for the last twelve months STAAR Surgical (STAA)|ChromaDex - Earnings per share for the last 12 months|ZimVie Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ANGO (AngioDynamics Inc)|CERS - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Alpha Teknova Inc TKNO|monogramorthopedics.com (MGRM) - Earnings per share for the last twelve months|STSS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Earnings per share for the last four quarters|Earnings per share for the last twelve months KORU Medical Systems, Inc. (KRMD)|Net earnings per share for the last 12 months Microbot Medical, Inc MBOT|Pro-Dex Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ZTEK (Zentek Ltd.)|Elutia Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Milestone Scientific Corp MLSS|NEXGEL, Inc (NXGL) - Earnings per share for the last twelve months|RVP: Earnings per share for the last four quarters|HBIO (Harvard Bioscience, Inc.) - Net earnings per share (EPS TTM)|Femasys (FEMY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) MHUA|Net earnings per share for the last four quarters Predictive Oncology Corp|Earnings per share for the last twelve months Callan JMB Inc CJMB|Atrion Corporation Inc. (ATRI) - Net earnings per one share for the last twelve months|neurometrix.com - Net earnings per share (EPS TTM)